Opinion
Video
Matthew Mutter, MD, shares data on Separo vessel sealing system for vasectomy
Author(s):
"I want to add that the safety profile was impeccable for this. No one experienced a [device-related] adverse event," says Matthew J. Mutter, MD.
In this video, Matthew J. Mutter, MD, highlights safety and efficacy data from an investigational device exemption (IDE) trial on the Separo vessel sealing system for vasectomy procedures. Mutter is the principal investigator of the safety profile study for the device and a general urologist in New Orleans, Louisiana.
Video Transcript:
This was a single-arm trial. The end point was what it would be for a vasectomy, and that's to make a man azoospermic after the procedure. Our limited patients, our 8 patients that we did, all of them at 6 months either reached azoospermia or [had] rare, non-modal sperm, which is perfectly acceptable within the AUA guidelines for a successful vasectomy. So, our end point was reached.
I want to add that the safety profile was impeccable for this. No one experienced a [device-related] adverse event. As far as pain scores were recorded, there was only 1 pain score above a 0 throughout the duration of the study.
This transcript was AI generated and edited by human editors for clarity.
